Literature DB >> 34277272

Idiopathic Retroperitoneal Fibrosis: An East African Diagnostic Challenge.

Sayed K Ali1, Katie Du2, Kelvin Orare1.   

Abstract

Retroperitoneal fibrosis (RPF) is a rare disease with variable etiology characterized by chronic inflammation and fibrosis of tissue surrounding the abdominal aorta and iliac arteries. The majority of cases of RPF remain idiopathic and mostly reported in men. Glucocorticoids remain key in the treatment of RPF. Little has been reported on RPF in sub-Saharan Africa.
Copyright © 2021, Ali et al.

Entities:  

Keywords:  diagnosis and treatment; east africa; kenya; retroperitoneal fibrosis; steroids

Year:  2021        PMID： 34277272      PMCID： PMC8281799          DOI： 10.7759/cureus.15683

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  19 in total

1.  Mycophenolate mofetil for maintenance of remission in idiopathic retroperitoneal fibrosis.

Authors:  R N Jois; N Kerrigan; D G I Scott
Journal:  Rheumatology (Oxford)       Date:  2007-01-11       Impact factor: 7.580

2.  Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis.

Authors:  Federico Alberici; Alessandra Palmisano; Maria L Urban; Federica Maritati; Elena Oliva; Lucio Manenti; Stefania Ferretti; Rocco Cobelli; Carlo Buzio; Augusto Vaglio
Journal:  Ann Rheum Dis       Date:  2013-05-21       Impact factor: 19.103

3.  Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis.

Authors:  Eric F H van Bommel; Tadek R Hendriksz; Antonius W L C Huiskes; Antoine G M Zeegers
Journal:  Ann Intern Med       Date:  2006-01-17       Impact factor: 25.391

4.  The response of retroperitoneal fibrosis to tamoxifen.

Authors:  C P Clark; D Vanderpool; J T Preskitt
Journal:  Surgery       Date:  1991-04       Impact factor: 3.982

5.  Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes.

Authors:  Tanaz A Kermani; Cynthia S Crowson; Sara J Achenbach; Harvinder S Luthra
Journal:  Mayo Clin Proc       Date:  2011-04       Impact factor: 7.616

6.  Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis.

Authors:  Augusto Vaglio; Maria G Catanoso; Lucia Spaggiari; Luca Magnani; Nicolò Pipitone; Pierluigi Macchioni; Lia Pulsatelli; Maria Nicastro; Gabriella Becchi; Domenico Corradi; Annibale Versari; Luigi Boiardi; Carlo Salvarani
Journal:  Arthritis Rheum       Date:  2013-09

7.  Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation.

Authors:  E F H van Bommel; I Jansen; T R Hendriksz; A L H J Aarnoudse
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889

Review 8.  Unusual presentation of idiopathic retroperitoneal fibrosis: case report.

Authors:  N Twahirwa; J Rees
Journal:  East Afr Med J       Date:  2008-05

9.  Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study.

Authors:  Andrew C Fry; Sadmeet Singh; Smita S Gunda; Greg B Boustead; Damian C Hanbury; Thomas A McNicholas; Ken Farrington
Journal:  Nephron Clin Pract       Date:  2008-03-07

10.  A case of retroperitoneal fibrosis secondary to chronic periaortitis.

Authors:  Mariam A Omar; Naushad Hassan Karim; Saeed Samnakay
Journal:  BJR Case Rep       Date:  2019-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.